Top Markets
Coin of the day
BillionToOne, Inc. BillionToOne, Inc.

BillionToOne, Inc.

BLLN
Rank in Stocks #3837
BillionToOne, Inc. is a specialized diagnostics company that innovates by... BillionToOne, Inc. is a specialized diagnostics company that innovates by precisely quantifying biological data to create advanced molecular diagnostic solutions. Central to their operations is a cutting-edge molecular counting platform, meticulously engineered to identify and measure individual DNA molecules, thereby significantly enhancing the precision of disease detection. Their product portfolio includes: UNITY Complete: A non-invasive prenatal screen that assesses a fetus's risk for aneuploidies, recessive genetic conditions, and fetal antigens, all from a simple maternal blood sample. Northstar Select: A liquid biopsy test designed to pinpoint specific mutations present in tumors, encompassing deletions, insertions, and point mutations. Northstar Response: A diagnostic tool that enables continuous tracking of cancer progression through detailed methylation assessment. Established in 2016, BillionToOne, Inc. conducts its operations from its headquarters located in Menlo Park, California.
Share Price
$99.89
Last synced: 2026-08-25
Market Cap
$4.59B
Change (1 day)
3.26%
Change (1 year)
-
Country
US
Trade BillionToOne, Inc. (BLLN)

Category

Stock price history for BillionToOne, Inc. (BLLN)
Highest end of day price: $94.78 on 2026-08-01

Lowest end of day price: $106.24 on 2025-11-01
Stock price history of BillionToOne, Inc. from 2025 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) -3.30%
2025 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$627.82 28.53%
US
$215.60 4.53%
US
$23.08 70.53%
CN
$334.93 102.12%
US
$154.62 30.70%
US